title: Post-penetrating keratoplasty glaucoma.
abstract: Post-penetrating keratoplasty (post-PK) glaucoma is an important cause of irreversible visual loss and graft failure. The etiology for this disorder is multifactorial, and with the use of new diagnostic equipment, it is now possible to elucidate the exact pathophysiology of this condition. A clear understanding of the various mechanisms that operate during different time frames following PK is essential to chalk out the appropriate management algorithms. The various issues with regard to its management, including the putative risk factors, intraocular pressure (IOP) assessment post-PK, difficulties in monitoring with regard to the visual fields and optic nerve evaluation, are discussed. A step-wise approach to management starting from the medical management to surgery with and without metabolites and the various cycloablative procedures in cases of failed filtering procedures and excessive perilimbal scarring is presented. Finally, the important issue of minimizing the incidence of glaucoma following PK, especially through the use of oversized grafts and iris tightening procedures in the form of concomitant iridoplasty are emphasized. It is important to weigh the risk-benefit ratio of any modality used in the treatment of this condition as procedures aimed at IOP reduction, namely trabeculectomy with antimetabolites, and glaucoma drainage devices can trigger graft rejection, whereas cyclodestructive procedures can not only cause graft failure but also precipitate phthisis bulbi. Watchful expectancy and optimal time of intervention can salvage both graft and vision in this challenging condition.
authors.affiliation: Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India. tanujdada@hotmail.com
authors.forename: Tanuj
authors.initials: T
authors.lastname: Dada
authors.forename: Anand
authors.initials: A
authors.lastname: Aggarwal
authors.forename: K B
authors.initials: KB
authors.lastname: Minudath
authors.forename: M
authors.initials: M
authors.lastname: Vanathi
authors.forename: Sunil
authors.initials: S
authors.lastname: Choudhary
authors.forename: Viney
authors.initials: V
authors.lastname: Gupta
authors.forename: Ramanjit
authors.initials: R
authors.lastname: Sihota
authors.forename: Anita
authors.initials: A
authors.lastname: Panda
mesh_terms: D000869:Anterior Eye Segment / Q000000981:diagnostic imaging; D000959:Antihypertensive Agents / Q000627:therapeutic use; D005901:Glaucoma / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007429:Intraocular Pressure; D032801:Iridectomy; D015948:Keratoplasty, Penetrating / Q000009:adverse effects*; D033401:Microscopy, Acoustic; D012307:Risk Factors; D014130:Trabeculectomy
chemical_list: D000959:Antihypertensive Agents